Cvi Holdings, LLC Bio Line Rx Ltd. Transaction History
Cvi Holdings, LLC
- $11.5 Million
- Q2 2024
A detailed history of Cvi Holdings, LLC transactions in Bio Line Rx Ltd. stock. As of the latest transaction made, Cvi Holdings, LLC holds 815,683 shares of BLRX stock, worth $342,586. This represents 4.05% of its overall portfolio holdings.
Number of Shares
815,683Holding current value
$342,586% of portfolio
4.05%Shares
1 transactions
Others Institutions Holding BLRX
# of Institutions
38Shares Held
4.34MCall Options Held
49.9KPut Options Held
122K-
Alyeska Investment Group, L.P. Chicago, IL1.95MShares$820,4130.01% of portfolio
-
Envestnet Asset Management Inc214KShares$89,8090.0% of portfolio
-
Values First Advisors, Inc.198KShares$82,9560.06% of portfolio
-
Atria Investments LLC Charlotte, NC134KShares$56,2690.0% of portfolio
-
Pvg Asset Management Corp Golden, CO124KShares$51,9030.3% of portfolio
About BioLineRx Ltd.
- Ticker BLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,524,500
- Market Cap $25.8M
- Description
- BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...